Trimedyne, Inc. announced earnings results for the first quarter ended December 31, 2018. For the quarter, the company reported revenues of $1,188,000, a decrease of 23% from revenues of $1,534,000 for the prior year quarter. As a result of this decrease, the company had a net loss for the current quarter of $31,000 or $0.25 per share, as compared to net income of $86,000 or $0.70 per share for the prior year quarter.